Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Author: Benzinga Insights | February 06, 2025 04:05pm

Gainers

  • Lipella Pharmaceuticals (NASDAQ:LIPO) shares increased by 158.9% to $6.68 during Thursday's pre-market session. The market value of their outstanding shares is at $8.0 million.
  • MBX Biosciences (NASDAQ:MBX) stock moved upwards by 29.86% to $14.61. The market value of their outstanding shares is at $488.2 million.
  • Relmada Therapeutics (NASDAQ:RLMD) shares moved upwards by 25.71% to $0.48. The market value of their outstanding shares is at $14.4 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) shares rose 25.27% to $11.2. The company's market cap stands at $7.7 million.
  • Rani Therapeutics Hldgs (NASDAQ:RANI) shares moved upwards by 20.83% to $1.74. The market value of their outstanding shares is at $57.9 million.
  • Invivyd (NASDAQ:IVVD) stock increased by 20.37% to $2.54. The market value of their outstanding shares is at $303.8 million.

Losers

  • Avinger (NASDAQ:AVGR) shares declined by 28.6% to $0.4 during Thursday's pre-market session. The market value of their outstanding shares is at $1.2 million.
  • Protagenic Therapeutics (NASDAQ:PTIX) shares declined by 27.37% to $0.27. The market value of their outstanding shares is at $1.9 million.
  • Pasithea Therapeutics (NASDAQ:KTTA) shares declined by 27.01% to $2.0. The company's market cap stands at $2.5 million.
  • Sensus Healthcare (NASDAQ:SRTS) shares decreased by 21.58% to $7.05. The market value of their outstanding shares is at $115.5 million. As per the news, the Q4 earnings report came out yesterday.
  • X4 Pharmaceuticals (NASDAQ:XFOR) stock fell 16.69% to $0.51. The company's market cap stands at $87.6 million.
  • Universe Pharmaceuticals (NASDAQ:UPC) shares fell 15.82% to $0.17. The company's market cap stands at $1.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AVGR IVVD KTTA LIPO MBX PTIX RANI RLMD RNAZ SRTS UPC XFOR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist